CARA THERAPEUTICS INC (CARA) Stock Cash Flow
NASDAQ:CARA - Nasdaq - US1407551092 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -95.53M | -118.51M | -85.47M | -88.44M | 8.41M | |||
| Depreciation Amortization | 271.00K | 259.00K | 250.00K | 250.00K | 210.00K | |||
| Change In Working Capital | -6.14M | 9.36M | -12.92M | 5.26M | -7.37M | |||
| Other non cash items | 27.15M | 16.82M | 19.42M | 22.84M | -6.74M | |||
| OPERATING CASH FLOW | -74.24M | -92.08M | -78.73M | -60.09M | -5.49M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.10M | -2.38M | -40.00K | -40.00K | -350.00K | |||
| Other Investing Activity | 16.63M | 45.84M | 128.75M | -4.71M | -19.93M | |||
| INVESTING CASH FLOW | 13.53M | 43.46M | 128.71M | -4.75M | -20.28M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 1.68M | 310.00K | 46.61M | 39.14M | |||
| Other Financing Activity | N/A | 36.47M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 34.48M | 38.15M | 310.00K | 46.61M | 39.14M | |||
| CHANGE IN CASH | -26.23M | -10.47M | 50.29M | -18.23M | 13.37M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -74.24M | -92.08M | -78.73M | -60.09M | -5.49M | |||
| Capital Expenditure | -3.10M | -2.38M | -40.00K | -40.00K | -350.00K | |||
| FREE CASH FLOW | -77.34M | -94.45M | -78.77M | -60.13M | -5.84M | |||
All data in USD